Please note: The license is valid for 12 months from the date the report is sent.
Dermatological drugs - new study showing you trends, partnerships, and predicted revenues
Where is the market for dermatological drugs heading? What are the commercial prospects for this market? Visiongain’s new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects.
Our 310 page report provides 220 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at world market, submarket, regional and national level. You will see financial results, interviews, trends, opportunities and revenue predictions.Forecasts from 2015-2025 and other analyses show you commercial prospects
Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter’s Five Forces), company profiles and commercial developments. Read the full transcript of an exclusive expert opinion interview from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales:
- Kathleen Deardorff, Chief Operating Officer (COO) at Photocure ASAYou will find prospects for key submarkets
In addition to analyses of the overall world market, you will see revenue forecasting of five world-level submarkets to 2025:
- Skin infection drugs market forecast 2015-2025
- Dermatitis drugs market forecast 2015-2025
- Acne drugs market forecast 2015-2025
- Psoriasis drugs market forecast 2015-2025
- Other dermatological drugs market forecast 2015-2025See revenue forecasts for products
How will leading drugs perform to 2025 at world level? Our study forecasts sales of 24 products, including these brands:
Discover how high revenues can go. You will see what’s happening, understanding trends, challenges and opportunities.What are the prospects for the leading regions and countries?
Our analyses show sustained growth in the dermatological drugs market, particularly in the emerging economies where growing affluence and rising government support will impact the growth of dermatological drugs.
In addition to analyses of the overall world market, you discover individual revenue forecasts for national and regional markets to 2025. Future trends within each region are examined. You will discover individual revenue forecasts for 12 leading national markets to 2025. There are many commercial opportunities to exploit in both developed and developing countries.
- Rest of the World
Our analyses show that emerging economies, particularly in South America and Asia, will continue to achieve high revenue growth to 2025. Various economic, geographical, and regulatory factors globally will influence the market.Leading companies and potential for market growth
Over the last few years, the market for dermatological drugs globally has witnessed a number of strategic acquisitions and restructuring. The global dermatological drugs market will reach $24.5bn in 2015, according to visiongain’s forecast. Rising demand for dermatological drugs, expanding healthcare coverage, the success of biological drugs, and antibacterial drug resistance will aid in the growth of the overall market to 2025.Our work shows you what organisations hold greatest potential. See profiles of 6 leading companies, including these:
Get Industry Insights. Simply.
- Latest reports & slideshows with insights from top research analysts
- 60 Million searchable statistics with tables, figures & datasets
- More than 25,000 trusted sources